Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical

Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical GlobeNewswire January 07, 2026 Amsterdam, the Netherlands, January 7, 2026 – Scenic Biotech, a pioneer in the field of modifier therapies for severe diseases, today announced a license and research agreement with Ono Pharmaceutical Co., Ltd. to utilize Scenic's Cell-Seq platform for the discovery of […]

MEXC Launches Spot DCA to Support Automated Investment Strategies

MEXC Launches Spot DCA to Support Automated Investment Strategies GlobeNewswire January 07, 2026 VICTORIA, Seychelles, Jan. 07, 2026 (GLOBE NEWSWIRE) — MEXC, the world's fastest-growing digital asset exchange and a pioneer of true zero-fee trading, announced the launch of Spot DCA, a smarter way to execute dollar-cost averaging strategies. MEXC is committed to providing a

DeFi Crypto Mutuum Finance (MUTM) Shares New Progress Update as Investor Base Expands Over 18,700

DeFi Crypto Mutuum Finance (MUTM) Shares New Progress Update as Investor Base Expands Over 18,700 GlobeNewswire January 07, 2026 DUBAI, United Arab Emirates, Jan. 07, 2026 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM), a new crypto project focused on decentralized lending, has shared updates on its product development as its reported holder count continues to rise.

DISCO Pharmaceuticals Enters License Agreement to Advance Novel Cancer Surfaceome Targeted Therapies

DISCO Pharmaceuticals Enters License Agreement to Advance Novel Cancer Surfaceome Targeted Therapies GlobeNewswire January 07, 2026 Collaboration with Amgen to advance a cancer target discovered using DISCO's proprietary surfaceome mapping technology Cologne, Germany, January 7, 2026 – DISCO Pharmaceuticals (“DISCO”), today announced an exclusive license agreement with Amgen to advance novel therapeutic candidates addressing a

TRREB: 2025 Ends with More Affordable Market and Paves the Way for Year of Recovery

TRREB: 2025 Ends with More Affordable Market and Paves the Way for Year of Recovery GlobeNewswire January 07, 2026 TORONTO, Jan. 07, 2026 (GLOBE NEWSWIRE) — Annual Greater Toronto Area (GTA) home sales declined in 2025 compared to 2024, as economic uncertainty weighed on consumer confidence. Over the same period, listing inventory remained elevated, allowing

AnalystView Market Insights: Healthcare Virtual Assistant Market to Grow at a 35.08% CAGR Through 2032, Reaching US$ 29.63 Billion, Led by Nuance Communications, Microsoft, and Amazon.com

San Francisco, USA, Jan. 07, 2026 (GLOBE NEWSWIRE) — The global Healthcare Virtual Assistant Market is entering a phase of rapid acceleration, fueled by advancements in conversational AI, mounting pressure on healthcare systems, and the growing need for intelligent, automated patient-support solutions. Valued at US$ 1,806.74 million in 2024, the market is projected to expand

AnalystView Market Insights: Healthcare Virtual Assistant Market to Grow at a 35.08% CAGR Through 2032, Reaching US$ 29.63 Billion, Led by Nuance Communications, Microsoft, and Amazon.com

AnalystView Market Insights: Healthcare Virtual Assistant Market to Grow at a 35.08% CAGR Through 2032, Reaching US$ 29.63 Billion, Led by Nuance Communications, Microsoft, and Amazon.com Market growth is supported by advancements in AI-powered product offerings, cloud-based deployment models, and expanding clinical functionalities, with increasing adoption across hospitals, clinics, and home care settings. According to

SNA Community Introduces AlgoEdge 5.0 as Brandon Mercer Highlights the Role of AI in Investment Education

SNA Community announced the release of AlgoEdge 5.0, an AI-supported system designed to assist learning and research in investment education. Led by founder and Chief Research Lead Brandon Mercer, the initiative explores how artificial intelligence can support analytical understanding in complex market environments. NEW YORK CITY, NY / ACCESS Newswire / January 7, 2026 /

Is MEDVi a Trusted GLP-1 Supplier for 2026? What to Know Before Choosing a Telehealth Weight Loss Platform

New York City, NY, Jan. 07, 2026 (GLOBE NEWSWIRE) — As demand for GLP-1 weight loss medications continues to rise in 2026, many consumers are actively searching for a reliable GLP-1 supplier that offers affordability, medical oversight, and flexible access. With brand-name GLP-1 medications often priced between $1,300 and $1,500 per month without insurance, cost

Scroll to Top